These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9789708)

  • 21. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Friedman JH; Jacques C; Rosenfeld M
    Mov Disord; 1999 May; 14(3):484-7. PubMed ID: 10348474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences with clozapine and olanzapine.
    Chatterton R
    Aust N Z J Psychiatry; 1998 Jun; 32(3):463. PubMed ID: 9672741
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine for l-dopa-induced psychosis in PD.
    Weiner WJ; Minagar A; Shulman LM
    Neurology; 2000 Apr; 54(7):1538. PubMed ID: 10751276
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of psychotic aspects of Parkinson's disease.
    Juncos JL
    J Clin Psychiatry; 1999; 60 Suppl 8():42-53. PubMed ID: 10335670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents.
    Kumra S; Jacobsen LK; Lenane M; Karp BI; Frazier JA; Smith AK; Bedwell J; Lee P; Malanga CJ; Hamburger S; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):377-85. PubMed ID: 9549958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Worsening of motor features of parkinsonism with olanzapine.
    Molho ES; Factor SA
    Mov Disord; 1999 Nov; 14(6):1014-6. PubMed ID: 10584679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of risperidone and olanzapine on the indications for clozapine.
    Ganguli R; Brar JS
    Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clozapine and olanzapine in the treatment of the psychotic disorders in Parkinson's disease].
    Chacón J
    Rev Neurol; 2004 Oct 1-15; 39(7):655-60. PubMed ID: 15490354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine for the treatment of psychosis in Parkinson's disease: a review.
    Auzou P; Ozsancak C; Hannequin D; Moore N; Augustin P
    Acta Neurol Scand; 1996 Nov; 94(5):329-36. PubMed ID: 8947285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
    Molho ES; Factor SA
    Curr Neurol Neurosci Rep; 2001 Jul; 1(4):320-8. PubMed ID: 11898537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine treatment of methamphetamine psychosis.
    Misra LK; Kofoed L; Oesterheld JR; Richards GA
    J Clin Psychopharmacol; 2000 Jun; 20(3):393-4. PubMed ID: 10831035
    [No Abstract]   [Full Text] [Related]  

  • 35. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Parkinson Study Group
    N Engl J Med; 1999 Mar; 340(10):757-63. PubMed ID: 10072410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
    van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
    Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of atypical antipsychotic drugs in patients with dementia.
    Motsinger CD; Perron GA; Lacy TJ
    Am Fam Physician; 2003 Jun; 67(11):2335-40. PubMed ID: 12800962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine to olanzapine.
    Millson RC; Delva NJ
    Am J Psychiatry; 1999 Jul; 156(7):1121. PubMed ID: 10401476
    [No Abstract]   [Full Text] [Related]  

  • 39. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
    Wolters EC; Jansen EN; Tuynman-Qua HG; Bergmans PL
    Neurology; 1996 Oct; 47(4):1085-7. PubMed ID: 8857751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.